This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Haruko Miura - Innovator in Stem Cell Biology
Introduction
Haruko Miura is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of stem cell biology, particularly in developmental and regenerative biology. His innovative work focuses on generating breast stem cells, which has important implications for medical research and treatment.
Latest Patents
Haruko Miura holds a patent titled "Means and methods for generation of breast stem cells." This invention relates to a method of generating cells capable of differentiating into a multicellular organoid unit that resembles the terminal ductal-lobular unit. The process involves dissociating mammary epithelial tissue to obtain cells and culturing them in the presence of a compound that elevates cAMP levels in a collagen gel. Under these conditions, the cells form a multicellular organoid unit, which facilitates the isolation of breast stem cells. The invention also encompasses methods for enriching these cells and differentiating them into organoids for testing compounds.
Career Highlights
Haruko Miura is affiliated with the Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt. His work at this esteemed research institution has allowed him to explore innovative methods in stem cell research, contributing to advancements in regenerative medicine.
Collaborations
Some of Haruko Miura's notable coworkers include Christina H. Scheel and Jelena R. Linnemann. Their collaborative efforts in research have further enhanced the understanding and application of stem cell technology.
Conclusion
Haruko Miura's contributions to stem cell biology through his innovative patent have the potential to revolutionize the field of regenerative medicine. His work exemplifies the importance of research in developing new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
